Quintás-Cardama A - Search Results

1

Azacitidine for the treatment of myelodysplastic syndrome.

Cataldo VD, Cortes J, Quintás-Cardama A. Cataldo VD, et al. Expert Rev Anticancer Ther. 2009 Jul;9(7):875-84. doi: 10.1586/era.09.61. Expert Rev Anticancer Ther. 2009. PMID: 19589026 Review.

2

Treatment of non-small-cell lung cancer with erlotinib or gefitinib.

Cataldo VD, Gibbons DL, Pérez-Soler R, Quintás-Cardama A. Cataldo VD, et al. N Engl J Med. 2011 Mar 10;364(10):947-55. doi: 10.1056/NEJMct0807960. N Engl J Med. 2011. PMID: 21388312 Review.

3

A prognostic model of therapy-related myelodysplastic syndrome for predicting survival and transformation to acute myeloid leukemia.

Quintás-Cardama A, Daver N, Kim H, Dinardo C, Jabbour E, Kadia T, Borthakur G, Pierce S, Shan J, Cardenas-Turanzas M, Cortes J, Ravandi F, Wierda W, Estrov Z, Faderl S, Wei Y, Kantarjian H, Garcia-Manero G. Quintás-Cardama A, et al. Clin Lymphoma Myeloma Leuk. 2014 Oct;14(5):401-10. doi: 10.1016/j.clml.2014.03.001. Epub 2014 May 6. Clin Lymphoma Myeloma Leuk. 2014. PMID: 24875590 Free PMC article.

4

Activity of 9-nitro-camptothecin, an oral topoisomerase I inhibitor, in myelodysplastic syndrome and chronic myelomonocytic leukemia.

Quintas-Cardama A, Kantarjian H, O'Brien S, Jabbour E, Giles F, Ravandi F, Faderl S, Pierce S, Shan J, Verstovsek S, Cortes J. Quintas-Cardama A, et al. Cancer. 2006 Oct 1;107(7):1525-9. doi: 10.1002/cncr.22186. Cancer. 2006. PMID: 16955510 Free article. Clinical Trial.

5

Homoharringtonine for the treatment of chronic myelogenous leukemia.

Quintás-Cardama A, Cortes J. Quintás-Cardama A, et al. Expert Opin Pharmacother. 2008 Apr;9(6):1029-37. doi: 10.1517/14656566.9.6.1029. Expert Opin Pharmacother. 2008. PMID: 18377344 Review.

6

Omacetaxine mepesuccinate--a semisynthetic formulation of the natural antitumoral alkaloid homoharringtonine, for chronic myelocytic leukemia and other myeloid malignancies.

Quintás-Cardama A, Cortes J. Quintás-Cardama A, et al. IDrugs. 2008 May;11(5):356-72. IDrugs. 2008. PMID: 18465678

7

Chronic myeloid leukemia: diagnosis and treatment.

Quintás-Cardama A, Cortes JE. Quintás-Cardama A, et al. Mayo Clin Proc. 2006 Jul;81(7):973-88. doi: 10.4065/81.7.973. Mayo Clin Proc. 2006. PMID: 16835977 Review.

8

Evaluation of the L-stereoisomeric nucleoside analog troxacitabine for the treatment of acute myeloid leukemia.

Quintás-Cardama A, Cortes J. Quintás-Cardama A, et al. Expert Opin Investig Drugs. 2007 Apr;16(4):547-57. doi: 10.1517/13543784.16.4.547. Expert Opin Investig Drugs. 2007. PMID: 17371201 Review.

9

The next generation of therapies for chronic myeloid leukemia.

Quintás-Cardama A, Cortés JE. Quintás-Cardama A, et al. Clin Lymphoma Myeloma. 2009;9 Suppl 4:S395-403. doi: 10.3816/CLM.2009.s.040. Clin Lymphoma Myeloma. 2009. PMID: 20007109

10

Nilotinib.

Quintás-Cardama A, Kim TD, Cataldo V, le Coutre P. Quintás-Cardama A, et al. Recent Results Cancer Res. 2010;184:103-17. doi: 10.1007/978-3-642-01222-8_8. Recent Results Cancer Res. 2010. PMID: 20072834 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page